产品特点
应用场景
特色产品
分子 | 货号 | 产品描述 | 订购/预购 |
---|---|---|---|
Cathepsin B | CTB-H5222 | Human Cathepsin B / CTSB Protein, His Tag (MALS verified) | |
Plasma Kallikrein/KLKB1 | KL1-H52H9 | Human Plasma Kallikrein / KLKB1 Protein, His Tag (active enzyme, MALS verified) | |
MMP-1 | MM1-H52H3 | Human MMP-1 Protein, His Tag (active enzyme, MALS verified) | |
MMP-9 | MM9-H5221 | Human MMP-9 Protein, His Tag (active enzyme) | |
MMP-9 | MM9-H5229 | Human MMP-9 Protein, His Tag (active enzyme) (MALS verified) | |
MMP-9 | MM9-H52H9 | Human MMP-9 (20-707) Protein, His Tag (active enzyme, MALS verified) | |
PLAU | PLU-H5228 | Human PLAU / uPA Protein, His Tag (activated by trypsin) (active enzyme) | |
PLAU | PLU-H5229 | Human PLAU / uPA Protein, His Tag | |
Cathepsin L | CAL-M52H3 | Mouse Cathepsin L / CTSL1 Protein, His Tag (MALS verified) | |
Cathepsin B | CTB-M52H9 | Mouse Cathepsin B / CTSB Protein, His Tag (MALS verified) | |
Plasma Kallikrein/KLKB1 | KL1-M52H9 | Mouse Plasma Kallikrein / KLKB1 Protein, His Tag | |
MMP-2 | MM2-M52H9 | Mouse MMP-2 (30-460) Protein, His Tag (active enzyme) | |
MMP-9 | MM9-M52H1 | Mouse MMP-9 (20-471) Protein, His Tag (active enzyme, MALS verified) | |
MMP-9 | MM9-C52H3 | Cynomolgus MMP-9 Protein, His Tag (active enzyme) |
分子 | 货号 | 产品描述 | 订购/预购 |
---|---|---|---|
MMAE | ADC-P005 | AGLink® ADC Conjugation Kit (MMAE, DAR2&4, 1mg) | |
Tetrazine | ADC-P006 | AGLink® ADC Conjugation Kit (Tetrazine, DAR2&4, 1mg) | |
DBCO | ADC-P007 | AGLink® ADC Conjugation Kit (DBCO, DAR2&4, 1mg) | |
Biotin | ADC-P008 | AGLink® ADC Conjugation Kit (Biotin, DAR2&4, 1mg) | |
MMAE | ADC-P009 | AGLink® ADC Conjugation Kit (MMAE, DAR2&4, 5mg) | |
Tetrazine | ADC-P010 | AGLink® ADC Conjugation Kit (Tetrazine, DAR2&4, 5mg) | |
DBCO | ADC-P011 | AGLink® ADC Conjugation Kit (DBCO, DAR2&4, 5mg) | |
Biotin | ADC-P012 | AGLink® ADC Conjugation Kit (Biotin, DAR2&4, 5mg) |
分子 | 货号 | 产品描述 | 订购/预购 |
---|---|---|---|
DM-1 | DM1-BLY73 | Biotinylated Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (MALS verified) | |
DM-1 | DM1-PLY73 | HRP conjugated Monoclonal Anti-DM-1&DM-4 Antibody,Mouse IgG1 | |
DM-1 | DM1-Y73 | Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (MALS verified) | |
DXD | DXD-BVM807 | Biotinylated Anti-DXD Antibody, Mouse IgG1, Avitag™ (MALS verified) | |
DXD | DXD-M684 | Monoclonal Anti-DXD&Exatecan Antibody, Mouse IgG1 (MALS verified) | |
DXD | DXD-PLM684 | HRP conjugated Monoclonal Anti-DXD&Exatecan Antibody, Mouse IgG1 | |
Eribulin | ERN-BMY12b | Biotinylated Rabbit Anti-Eribulin Antibody, Rabbit IgG (1M1G11) | |
Eribulin | ERN-MY2012b | Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M1G11) | |
Eribulin | ERN-MY2063b | Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) | |
Eribulin | ERN-PLM12b | HRP conjugated Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M1G11) | |
MMAE | MME-BLS104 | Biotinylated Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (MALS verified) | |
MMAE | MME-M5252 | Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (MALS verified) | |
MMAE | MME-PLS104 | HRP conjugated Monoclonal Anti-MMAE&MMAF Antibody,Mouse IgG1 | |
PTX | PTX-S343 | Monoclonal Anti-PTX Antibody, Mouse IgG2a (MALS verified) | |
SN38 | SN8-BVM808 | Biotinylated Anti-SN38 Antibody, Mouse IgG1, Avitag™ (MALS verified) | |
SN38 | SN8-M685 | Monoclonal Anti-SN38 Antibody, Mouse IgG1 (MALS verified) | |
SN38 | SN8-PLM685 | HRP conjugated Monoclonal Anti-SN38 Antibody, Mouse IgG1 |
分子 | 货号 | 产品描述 | 中和活性 | 应用 |
---|---|---|---|---|
Adalimu*ab | ADB-Y19 | Anti-Adalimu*ab Antibodies (AY19) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Adalimu*ab | ADB-Y23b | Anti-Adalimu*ab Antibodies (AY23b) (recommended for PK/PD) | Non-Neutralizing Antibody | PK bridging ELISA; Indirect ELISA |
Bevacizu*ab | BEB-Y10 | Anti-Bevacizu*ab Antibodies (AY10) (MALS verified, recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-Y12 | Anti-Bevacizu*ab Antibodies (AY12) (recommended for neutralizing assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-Y9 | Anti-Bevacizu*ab Antibodies (AY9) (recommended for ADA assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Bevacizu*ab | BEB-BY13 | Biotinylated Anti-Bevacizu*ab Antibodies (AY13) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA;Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-Y27 | Anti-Cetuxi*ab Antibodies (AY27) (recommended for ADA assay) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-Y31 | Anti-Cetuxi*ab Antibodies (AY31) (Non-Neutralizing) | Non-Neutralizing Antibody | ADA assay; Indirect ELISA |
Cetuxi*ab | CEB-Y28 | Anti-Cetuxi*ab Antibodies (AY28) | Neutralizing Antibody | ADA assay; Neutralizing assay; Indirect ELISA |
Cetuxi*ab | CEB-BY31 | Biotinylated Anti-Cetuxi*ab Antibodies (AY31) (recommended for PK/PD) | Non-Neutralizing Antibody | PK bridging ELISA; Indirect ELISA |
Rituxi*ab | RIB-Y36 | Anti-Rituxi*ab Antibodies (AY36) (recommended for ADA assay) | Neutralizing Antibody | ADA assay;Neutralizing assay; Indirect ELISA |
Rituxi*ab | RIB-Y37 | Anti-Rituxi*ab Antibodies (AY37) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA;Neutralizing assay;Indirect ELISA |
Rituxi*ab | RIB-Y35c | Anti-Rituxi*ab Antibodies (MALS verified) | Non-Neutralizing Antibody | ADA assay; Indirect ELISA |
Trastuzu*ab | TRB-Y5b | Anti-Trastuzu*ab Antibodies (AY5b) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA |
Trastuzu*ab | TRB-Y1b | Anti-Trastuzu*ab Antibodies (AY1b) (recommended for PK/PD) | Neutralizing Antibody | PK bridging ELISA; Neutralizing assay; Indirect ELISA |
The purity of Human Her2, His Tag (Cat. No. HE2-H5225) was more than 90% and the molecular weight of this protein is around 80-95 kDa verified by SEC-MALS.
Immobilized Human TROP-2, His Tag (Cat. No. TR2-H5223) at 1 μg/mL (100 μL/well) can bind Mouse Monoclonal Antibody Against Human TROP-2, Mouse IgG1 with a linear range of 0.1-2 ng/mL (QC tested).
Immobilized Human PSMA, His Tag (Cat. No. PSA-H52H3) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human PSMA Antibody, Human IgG1 with a linear range of 0.3-39 ng/mL (Routinely tested).
Anti-LIV-1 mAb captured on CM5 chip via anti-human IgG Fc antibody can bind Human LIV-1, His Tag (Cat. No. LV1-H5223) with an affinity constant of 5.24 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Herceptin (Trastuzumab) captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human Her2, His Tag (Cat. No. HE2-H5225) with an affinity constant of 1.07 nM as determined in a SPR assay.
Loaded Mouse Nectin-4, His Tag (Cat. No. NE4-M52H3) on HIS1K Biosensor, can bind Human Nectin-1, Fc Tag (Cat. No. PV1-H5253) with an affinity constant of 0.12 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
2e5 of anti-ROR1 CAR-293 cells were stained with 100 μL of 10 μg/mL of Human / Cynomolgus / Rhesus macaque ROR1 (39-151, Ig-like domain), His Tag (Cat. No. RO1-H5221) and negative control protein respectively, washed and then followed by PE-anti-His Tag and analyzed with FACS (Routinely tested).
相关阅读:
相关阅读:
DAR 4 & DAR 2 ADC的HIC-HPLC分析
DAR 4 & DAR 2 ADC的HER2抗原结合力分析
DAR 4 & DAR 2 ADC的SEC-HPLC分析,聚体< 5%
DAR 4 & DAR 2 ADC的人血浆(体外)稳定性。DAR 4 & DAR 2 ADC在人血浆(体外)中稳定无降解
DAR 4 & DAR 2 ADC的体外细胞杀伤活性验证
1. 最小反应规格是多少?
200ug,所用试剂等比例缩小,但反应体积太小会影响回收率,因为在脱盐等过程中会有固定损失。
2. 抗体浓度是否必须达到11mg/ml?
低至1mg/ml也可以反应,但此时体系变大,酶和底物浓度降低,需延长反应时间至48h来获得理想DAR值。
3. 抗体种属是否有要求?
人源抗体没有任何问题,鼠抗和兔抗比较复杂,有个别不易偶联,可延长反应时间来解决。
4. 能否用于工艺放大生产?
可提供mg—g级的定制服务。
The EC50 value of anti-MMAE antibody to MMAE-conjugated hRS7 (MMAE-ADC) was 0.12 μg/ml. The unconjugated hRS7 antibody was used as negative control
Immobilized Disitamab Vedotin (RC48) at 0.2 μg/mL (100 μL/well) can bind Mouse Anti-MMAE Antibody, Mouse IgG1 (Cat. No. MME-M5252) with a linear range of 0.1-2 ng/mL (QC tested).
检测方法 | 线性范围 (µg/mL) |
灵敏度 (µg/mL) |
优势 | 劣势 |
Antigen-capture ELISA | — | — | 方法简单,通用性好 | 背景值高,无活性 |
Anti-idiotypic capture ELISA | 0.156-10 | 0.156 | 解决了CD20获得难的问题,方法简单 | 背景高,只适用于美罗华biosimilar |
Bridging ELISA by anti-idiotypic antibodies | 0.012-0.78 | 0.012 | 解决了CD20获得难的问题,灵敏度好,背景低 | 只适用于美罗华biosimilar |
相关阅读: